Editas Medicine, Inc.
General ticker "EDIT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $178.9M (TTM average)
Editas Medicine, Inc. follows the US Stock Market performance with the rate: 52.9%.
Estimated limits based on current volatility of 4.9%: low 2.17$, high 2.39$
Factors to consider:
- Total employees count: 246 (-7.2%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Insufficient funding, Commercialization delays, Intellectual property risks, Labor/talent shortage/retention, Security breaches
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.12$, 3.29$]
- 2025-12-31 to 2026-12-31 estimated range: [1.00$, 2.79$]
Financial Metrics affecting the EDIT estimates:
- Positive: with PPE of -0.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: 18.93 < Shareholder equity ratio, % of 39.31 <= 41.86
- Positive: Investing cash flow per share per price, % of 155.88 > -0.66
- Negative: Operating cash flow per share per price, % of -202.15 <= 0.33
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Inventory ratio change, % of -16.25 <= -0.75
Short-term EDIT quotes
Long-term EDIT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $19.71MM | $78.12MM | $32.31MM |
| Operating Expenses | $245.66MM | $247.30MM | $283.47MM |
| Operating Income | $-225.95MM | $-169.18MM | $-251.15MM |
| Non-Operating Income | $5.52MM | $15.96MM | $14.06MM |
| R&D Expense | $174.96MM | $177.65MM | $199.25MM |
| Income(Loss) | $-220.43MM | $-153.22MM | $-237.09MM |
| Profit(Loss)* | $-220.43MM | $-153.22MM | $-237.09MM |
| Stockholders Equity | $360.68MM | $349.10MM | $134.27MM |
| Assets | $514.32MM | $499.15MM | $341.59MM |
| Operating Cash Flow | $-177.35MM | $-132.18MM | $-210.28MM |
| Capital expenditure | $4.12MM | $4.72MM | $8.83MM |
| Investing Cash Flow | $114.07MM | $-3.73MM | $162.15MM |
| Financing Cash Flow | $1.28MM | $118.04MM | $56.03MM |
| Earnings Per Share** | $-3.21 | $-2.02 | $-2.88 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.